Sensitive

TPMT *3C — thiopurine tolerance

TPMT · rs1142345

Where this position leads

Condition: Thiopurine Dosing (TPMT and NUDT15)

Drug: Thiopurines

rs1142345 Condition: Thiopurine Dosing (TPMT and NUDT15) Thiopurine Dosing (TPMT and NUDT15) Condition Drug: Thiopurines Thiopurines Drug rs1142345 rs1142345 TPMT

What ClinVar records

Classification Likely benign; other for Thiopurine S-methyltransferase deficiency; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 5 submitters), last evaluated 2024-07-01. ClinVar record 12725 NM_000367.5(TPMT):c.719A>G (p.Tyr240Cys)

What this is ClinVar's aggregate record for this position (as of its 2026-10-19 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

What each result means

C/C Two copies of TPMT*3C — very low or absent enzyme activity. Standard thiopurine doses can cause severe, life-threatening myelosuppression, and CPIC recommends drastically reduced dosing or an alternative drug. This is one of the clearest gene-drug pairs in medicine.
T/C One copy of TPMT*3C, a no-function allele. TPMT breaks thiopurines down; with one working copy the drug builds up more than expected, and CPIC recommends starting azathioprine, mercaptopurine or thioguanine at a reduced dose with closer blood-count monitoring.
T/T No copy of *3C at this position. Normal TPMT activity is the usual result, though other TPMT alleles exist.
This is a pharmacogenomic result with a published dosing guideline behind it. Tell a prescriber or pharmacist rather than acting on it — and never stop or change a prescribed medicine on the strength of a genotype.
Source

What people read about alongside this

Papers in Europe PMC whose title or abstract names both this rsID and that subject. A shared paper means somebody wrote about the two together — it is not a claim that this position explains the subject.

In the news

2026-01-08 · Maud Maillard et al., CPIC, published in Clinical Pharmacology & Therapeutics

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update

CPIC updated its long-standing TPMT/NUDT15 thiopurine dosing guideline (covering azathioprine, mercaptopurine, thioguanine), adding a new recommendation for people who carry a reduced-function variant in both genes at once -- a 'compound TPMT/NUDT15 intermediate metabolizer' phenotype -- who now get a larger starting-dose reduction than previously recommended. This directly updates the guidance behind the two variants this site already profiles: TPMT *3C (rs1142345) and NUDT15 *3 (rs116855232).

Questions about rs1142345

What is rs1142345?

rs1142345 is a single position in the genome, in or near the TPMT gene. Published research associates it with tpmt *3c — thiopurine tolerance. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs1142345 linked to?

On MyGeneLog this position is linked to Thiopurine Dosing (TPMT and NUDT15). The research behind each link, and its sources, are set out on that condition page.

Does rs1142345 affect how medicines work?

TPMT carries pharmacogenomic findings for Thiopurines. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.

What do people read about alongside rs1142345?

Subjects that appear in the title or abstract of the same papers as this rsID include alcohol and the flush (1 papers), blood sugar and insulin (1 papers), liver (1 papers). A shared paper means somebody wrote about the two together; it is not a claim that this position explains the topic.

Does having rs1142345 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs1142345 come from?

CPIC Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update, Clinical Pharmacology & Therapeutics (PMID 30447069). Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

TPMT *3C — thiopurine tolerance (rs1142345). MyGeneLog™. https://www.mygenelog.com/variants/rs1142345

← See all variants